RenovoRx Inc
NASDAQ:RNXT
| Market Cap (Intraday) | 45.07M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $1.32 |
| 50-Day MA | $1.25 |
| 200-Day MA | $1.15 |
RenovoRx Inc Stock, NASDAQ:RNXT
2570 West El Camino Real, Suite 320, Mountain View, California 94040
United States of America
Phone: +1.650.284.4433
Number of Employees: 8
Description
RenovoRx, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of a therapy platform to deliver chemotherapy. Its therapy platform includes RenovoTAMP, a therapy platform designed for targeted delivery of chemotherapy enabling localized treatment of solid tumors. The company was founded by Ramtin Agah and Kamran Najmabadi in December 2009 and is headquartered in Mountain View, CA.